Elevance Health (ELV) investor relations material

Scale and strategy

• 44.9M medical members across affiliated health plans and ~104M consumers served; footprint spans 24 Medicare markets and 24 Medicaid markets, including Puerto Rico.

• Enterprise ambition: be a lifetime, trusted health partner by lowering healthcare costs and simplifying access, navigation and use.

• Carelon served 92.4M consumers and processed 334.7M annual adjusted scripts on a rolling-12-month basis as of Q2 2026.

Governance and board

• Board has 10 of 11 independent directors, a separate independent chair and CEO, and fully independent Audit, Compensation & Talent, Finance and Governance committees.

• Board averages 64.5 years of age and 8.2 years of tenure; 8 of 11 directors are female and/or racially or ethnically diverse, and two independent directors joined in the past year.

• Annual Board, committee and individual director evaluations are externally led; directors oversee refreshment, succession planning, enterprise risk and AI governance and use.

• Shareholder safeguards include majority voting, proxy access, executive incentive clawbacks, stock ownership requirements and a policy against short sales, hedging and pledging.

Executive compensation

• CEO target compensation was 79% long-term incentive/equity at target; other NEOs were 72%, with pay tied to financial, operational and strategic performance measures.

• Long-term awards include performance stock units, restricted stock units and options; equity awards vest over three years, and Say-on-Pay received 96% support at the 2026 shareholder meeting.